Oarsman Capital, Inc. Twist Bioscience Corp Transaction History
Oarsman Capital, Inc.
- $562 Million
- Q4 2024
A detailed history of Oarsman Capital, Inc. transactions in Twist Bioscience Corp stock. As of the latest transaction made, Oarsman Capital, Inc. holds 285 shares of TWST stock, worth $10,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
285
Previous 285
-0.0%
Holding current value
$10,240
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TWST
# of Institutions
278Shares Held
66.5MCall Options Held
118KPut Options Held
40.2K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.24MShares$224 Million2.64% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.89MShares$212 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$211 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$195 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.81MShares$137 Million0.46% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.03B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...